Home
Courses
Research
Biology Dept
CSU, Stanislaus
Letters of Recommendation Request Form
 
 
 
 
 

Lecture 5                                                              

Spread and Replication                                           Reading: pg. 157 –165

  • Surface vs. systemic infection (fig. 15.1, pg. 157, fig. 15.2, fig. 15.3, pg. 158)
  • Replication rates (fig. 15.6, pg. 159)
  • Mechanisms of spread
    • Spread to lymph and blood (fig. 15.7, pg. 160)
    • Spread from blood
    • Spread via nerves (fig. 15.9, pg. 161)
    • Spread via cerebrospinal fluid
    • Spread via other routes
  • Genetic determinants of spread
  • Other factors
  • Molecular basis (fig. 15.11, pg. 164)
  • Host factors (fig. 15.12, pg. 165

 

Parasite Survival Strategies, etc                   Reading: pg. 167 – 180

  • Strategies to evade innate defenses
    • Killing or avoiding being killed by phagocytes (fig. 16.1, pg. 168)
    • Interfering with ciliary action
    • Interfering with complement’s alternative pathway (fig. 16.2, pg. 169)
    • Producing iron binding molecules
    • Blocking interferons
  • Strategies to evade adaptive defenses
  • Immunosuppression
  • Persistent infections
  • Reactivation

 

Pathologic consequences of infection     Reading: pg. 183 – 197

  • General scheme (fig. 17.1, pg. 183)
  • Pathology caused directly by microorganism
    • Direct tissue damage (fig. 17.2, pg. 184)
    • Exotoxins of importance (fig. 17.3, pg. 185)
  • Pathologic activation of natural immune mechanisms (fig. 17.6, pg. 188)
  • Pathologic consequences of the immune response
    • Hypersensitivity (fig. 17.8, pg. 191)
    • Cell-mediated responses (fig. 17.11, pg. 193)
  • Skin rashes (fig. 17.12, pg. 194)
  • Viruses and cancer (fig. 17.13, pg. 195, fig. 17.14, pg. 195)

 

Pathology of Infection
(p. 157-197)

Spread and replication

Parasite survival Strategies

Pathologic consequences of infection

 

Spread and Replication: Surface vs. systemic infection

p    Determining factors

n    Temperature – temperature-sensitive microbes

p   Rhinoviruses

p   Mycobacterium leprae

n    Site of budding

p   Influenza and parainfluenza viruses (fig.15.2)

 

Spread and Replication: Surface vs. systemic infection

p    Many microbes have to invade deeper tissue

n    fail to spread and multiply at site of initial infection

p  Measles and typhoid

n    route of infection is different from site of replication and shedding.

p   Mumps - infect via respiratory route; multiply in salivary glands

p   hepatitis A - infect via alimentary route; multiply in liver

 

Spread and Replication: Replication rates

p   Varies from 20 min to weeks in vitro

p   Microbes multiply faster in vitro than in vivo

Spread and Replication: Mechanisms of spread

p    Spread to lymph and blood

n    microbes encounter a variety of defenses:

p   Tissue fluids with antimicrobial substances (antibody, complement)

p   Local macrophages (subcutaneous and submucosal)

p   Physical barrier of local tissue structure – prevents spreading

p   Lymphatic system – where phagocytes and other defenses awaits (fig. 15.7)

 

Spread and Replication: Mechanisms of spread

p    Spread from blood

n    Viremia and bacteremia

n    Microbes may be:

p   free – exposed to immune defenses

p   Associated with circulating cells - protect and carry them around body

§    Epstein-Barr virus and rubella, and intracellular bacteria (Listeria, Brucella) – protected inside lymphocytes or monocytes
§    Malaria - erythrocytes

n    Microbes invade only certain organs and tissues:

p   Specific receptors for microbe

p   Random localization

p   Accumulation of circulating microbes in areas with local inflammation

n    Microbe shed from body surface or into bloodstream

 

Spread and Replication: Mechanisms of spread

p   Spread from nerves

n   Viruses reach CNS via axons

n   Few host defenses to control viral spread

n   Fig. 15.9: routes of invasion of the CNS

n   Uncommon route of spread to CNS

p  olfactory nerves

§    Amoeba in freshwater pools - causes meningoencephalitis in swimmers

p  Viruses and bacteria in nasopharynx

§    Meningococci, poliovirus

p   Spread from cerebrospinal fluid

n   After crossing blood-cerebrospinal barrier microbes can:

p  invade neural tissues – echovirus, mumps virus

p  Multiply locally and infect ependymal and meningeal cells – N. meningitidis, H. influenzae

p   Spread via other routes

n   organ to organ via pleural or peritoneal cavity

n   Infections of:

p  peritoneal cavity - injury or disease of abdominal organs

p  Pleural cavity – chest wounds or lung infections

 

Spread and Replication: Genetic determinants of spread

p   host genetic determinants

n   Affect susceptibility to pathogens

n   Example: Sickle cell gene

p  Wildtype

p  Sickle cell gene - nucleotide change in DNA

§    Sickle cell trait (heterozygous form)
§    confers resistance to severe forms of malaria
§    selected for in malarial regions of world

p   Microbial genetic determinants

n   Virulence factors:

p  encoded by microbial genes

p  Includes adhesion, penetration into cells, antiphagocytic activity, toxin production, interactions with immune system

n   Genetic changes due to:

p  High mutation rates of surface antigens

p  Acquisition of genetic elements

n   Molecular basis of microbial pathogenicity (fig. 15.11)

 

Spread and Replication:

p   Molecular basis

p   Other factors

n   brain can influence immune responses via

p  Shared chemical messengers with endocrine and immune system

n   Host factors (fig. 15.12)

p   Host factors

 

Parasite survival strategies

 

Strategies to evade innate defenses

p         Killing or avoiding being killed by phagocytes

p        Interfering with ciliary action

n        Impairment or destruction of ciliary cells

p        Interfere with complement’s alternative pathway

p         Producing iron binding molecules

n         Siderophores

n         Take iron away from host iron-complexing proteins

p         Blocking interferons

n         block actions of interferons (IFNa, IFNb)

 

Strategies to evade adaptive defenses

p   More sophisticated

n   Lymphocytes (B and T cells) – recognize shape or amino acid peptides

p  Capsules

§    recognized by B cell à production of antibodies, opsonization and phagocytosis

p  Peptides

§    presented on macrophage surface à detected by T cells à cytotoxic and other defenses

p        Cause a rapid “hit-and-run” infection

n         rhinoviruses, rotaviruses

p        Concealment of antigens from host

n         Remain inside cells – latent viruses (HSV)

n         Colonizing privileged sites 

p        Hydatid cysts

§        form by Echinococcus granulosus (tapeworm)
§        Liver, lung, brain

p        Integration into host DNA (retroviruses)

n         Mimicry – microbe mimics host antigens

n        host produces autoantibodies à autoimmunity

p       Group A beta-hemolytic streptococci – mimic cardiac muscle à rheumatic heart disease

n         Microbes cover surfaces with host molecules

p        Antigenic variation

n        Mechanisms involved

p        Mutation

§        antigenic drift

p        Recombination

§       exchanged of genetic information

p        Gene switching

§        switch from use of one gene to another

 

Immunosuppression

p    Temporary or long-lasting

p   Immunosuppresssive effects

n   actual infection of immune cells à impair cell function or cell death

n   release immunosuppressive molecules

 

Staphylococci toxins – potent T cell mitogens

p   Interference with signaling between immune cells

n   Fake molecules or fake cell receptors for host molecules

p  Glycoprotein C (Herpes simplex virus) –interferes with complement activation

n   Other proteins:

p  interfere with apoptosis

p  induce apoptosis

p   Interference with local expression of immune response in tissues

n   Destruction of IgA by protease

n   Inactivation of complement proteins

n   Production of Fc receptor molecules (Fig 16.8)

 

p   Persistent infections

n    several forms:

p  Infectious (hep B)

p  Low infectivity (adenoviruses)

p  Non-infectious (latent, HSV)

n    Latent infections can be:

p  Associated with chronic diseases, cancers

p  Reactivated

Reactivation

p         Two stages in reactivation

n          Stage A: resumption of  viral activity

p        HSV - triggered by sensory stimuli, fevers or hormones

n          Stage B: Spread and replication of reactivated virus

p        HSV – travels down axon to mucosal surface, infect and spread forming a vesicle filled with viruses

p        Can be controlled by immune system

§        Cold sores – due to poor lymphocyte response
§        Zoster – due to declining cell-mediated responses

 

Pathologic consequences of infection

p   General scheme

p   Symptoms of disease caused by:

n   Microbe

n   Toxins

n   Induction of immune response

 

Direct tissue damage

 

Exotoxins

p   A-B toxins - consist of two parts

p  A portion = Toxic or active enzyme

p  B portion = Binding component  - Binds to specific host cell receptors

n   Example: Diphtheria toxin

 

p   Exotoxins inactivated à toxoid (vaccine) à diphtheria, tetanus

 

p    Pathologic activation of natural immune mechanisms

n    Overactivity cause damage to host tissues

p   Endotoxins

§    Activation of immune response and clotting pathway (fig. 17.6)

p   Increased levels of TNF and activation of complement

 

Hypersensitivity

p   lead to tissue damage due to over-stimulation or prolonged response of adaptive immunity

  • Type III- Immune complex

  • Type IV hypersensitivity

  • Skin rashes

 

Pathologic consequences of infection

p   Viruses and cancer

n   Tumor viruses - cause malignant changes within cells

n   Human cancers associated with tumor viruses